|
WDR89 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.45630002396291E-09 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.61040003344004E-09 |
| Normal-vs-Stage2 |
1.5251399999916E-05 |
| Normal-vs-Stage3 |
4.58979999995446E-06 |
| Normal-vs-Stage4 |
2.817800E-03 |
| Stage1-vs-Stage2 |
8.607000E-01 |
| Stage1-vs-Stage3 |
8.822600E-01 |
| Stage1-vs-Stage4 |
6.041000E-01 |
| Stage2-vs-Stage3 |
9.653600E-01 |
| Stage2-vs-Stage4 |
4.999200E-01 |
| Stage3-vs-Stage4 |
5.342000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.32740002217946E-09 |
| Normal-vs-AfricanAmerican |
1.34670000040416E-07 |
| Normal-vs-Asian |
2.184400E-01 |
| Caucasian-vs-AfricanAmerican |
9.786000E-01 |
| Caucasian-vs-Asian |
1.618040E-01 |
| AfricanAmerican-vs-Asian |
1.563960E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.05980027373687E-10 |
| Normal-vs-Female |
1.554910E-04 |
| Male-vs-Female |
4.151700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.23560000000612E-05 |
| Normal-vs-Extreme_Weight |
6.66570021401469E-10 |
| Normal-vs-Obese |
2.25670000020273E-07 |
| Normal-vs-Extreme_Obese |
7.187900E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.748000E-01 |
| Normal_Weight-vs-Obese |
8.797400E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.352200E-01 |
| Extreme_Weight-vs-Obese |
2.784600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.178600E-01 |
| Obese-vs-Extreme_Obese |
7.741200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.150100E-02 |
| Normal-vs-Age(41-60Yrs) |
5.85919999962492E-07 |
| Normal-vs-Age(61-80Yrs) |
1.02550001823687E-09 |
| Normal-vs-Age(81-100Yrs) |
5.46140000001749E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.416600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.343790E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.485670E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.274100E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.649700E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.294400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.25350000046431E-07 |
| Normal-VS-Type2 PRCC |
1.8539999535605E-09 |
| Normal-VS-KIRP CIMP |
1.022770E-01 |
| Normal-VS-Unclassified PRCC |
1.585590E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.127700E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.010800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.426600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.383220E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.111900E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.040600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.45059994519181E-09 |
| Normal-vs-N1 |
1.677630E-02 |
| Normal-vs-N2 |
1.62770000000645E-06 |
| N0-vs-N1 |
8.380200E-03 |
| N0-vs-N2 |
6.152100E-02 |
| N1-vs-N2 |
3.58099999997474E-06 |
|
|
